Program PDF Saturday, March 28, 2020 Updated: 02-14-20 Special ‐ Events and Meetings Congenital Heart Disease ‐ Scientific Session #5002 Session #602 Fellowship Administrators in Cardiovascular Education and ACHD Cases That Stumped Me Training Meeting, Day 2 Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. Saturday, March 28, 2020, 7:30 a.m. ‐ 5:30 p.m. Room S105b Marriott Marquis Chicago, Great Lakes Ballroom A CME Hours: 1.5 / CNE Hours: CME Hours: / CNE Hours: Co‐Chair: C. Huie Lin 7:30 a.m. Co‐Chair: Karen K. Stout Fellowship Administrators in Cardiovascular Education and Training Meeting, Day 2 8:00 a.m. LTGA, Severe AV Valve Regurgitation, Moderately Reduced EF, And Atrial Acute and Stable Ischemic Heart Disease ‐ Scientific Arrhythmia Session #601 Elizabeth Grier Treating Patients With STEMI: What They Didn't Teach You in Dallas, TX Fellowship! Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. 8:05 a.m. Room S505a ARS Questions (Pre‐Panel Discussion) CME Hours: 1.5 / CNE Hours: Elizabeth Grier Dallas, TX Co‐Chair: Frederick G. Kushner Co‐Chair: Alexandra J. Lansky 8:07 a.m. Panelist: Alvaro Avezum Panel Discussion: LTGA With AVVR And Reduced EF Panelist: William W. O'Neill Panelist: Jennifer Tremmel Panelist: Jonathan Nathan Menachem Panelist: Joseph A. Dearani 8:00 a.m. Panelist: Michelle Gurvitz Case of a Young Women With STEMI Panelist: David Bradley Jasjit Bhinder Valhalla, NY 8:27 a.m. ARS Questions (Post‐Panel Discussion) 8:05 a.m. Elizabeth Grier Young Women With STEMI: Something Doesn't Make Sense.... or Does It? Dallas, TX Jennifer Tremmel Palo Alto, CA 8:30 a.m. Tetralogy of Fallot, Severe PR, Considering Pregnancy 8:15 a.m. Valeria Edit Duarte Panel Discussion on STEMI in Young Women Bellaire, TX 8:30 a.m. 8:35 a.m. Case of a Patient Living in Remote Area With No Access to Primary PCI ARS Questions (Pre‐Panel Discussion) Carlos Andres Gonzalez‐Lengua Valeria Duarte New York, NY Dedham, MA 8:35 a.m. 8:37 a.m. Barriers to Care in STEMI: Literally And Figuratively Panel Discussion: TOF, Severe PR, Considering Pregnancy Alvaro Avezum Sao Paulo, Brazil Panelist: Candice K. Silversides Panelist: Swee Chye Quek 8:45 a.m. Panelist: Anne Marie Valente Panel Discussion on Social And Physical Barriers to Care in STEMI Panelist: Susan Gerber 9:00 a.m. 8:57 a.m. Case of a Patient With STEMI And Refractory VF ARS Questions (Post‐Panel Discussion) David Berg Valeria Duarte Boston, MA Dedham, MA 9:15 a.m. 9:00 a.m. Panel Discussion Around Heroic Measures in STEMI Complicated by End‐Stage Fontan With Liver Dysfunction: How to Manage? Refractory VF Rose Tompkins Los Angeles, CA 9:05 a.m. ARS Questions (Pre‐Panel Discussion) Rose Tompkins Los Angeles, CA 9:07 a.m. Program PDF Saturday, March 28, 2020 Updated: 02-14-20 Panel Discussion: End‐Stage Fontan With Liver Dysfunction 8:00 a.m. Low Risk Aortic Stenosis: TAVR Is The Best First Choice! Panelist: Heather L. Bartlett Samir R. Kapadia Panelist: Anitha S. John Cleveland, OH Panelist: Jonathan Nathan Menachem Panelist: Fred Wu 8:10 a.m. Low Risk Aortic Stenosis: SAVR Is The Best Option! 9:27 a.m. Michael J. Reardon ARS Questions (Post‐Panel Discussion) Houston, TX Rose Tompkins Los Angeles, CA 8:20 a.m. Panel Discussion With Audience Question and Answer Non Invasive Imaging (Echocardiography, Nuclear, PET, MR & CT) ‐ Scientific 8:30 a.m. Session #603 Bicuspid Aortic Valve: TAVR Is as Good as SAVR Challenges in Decision‐Making in Cardiac Imaging: Patient Vs Society Jeffrey J. Popma Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. Newton, MA Room S501a CME Hours: 1.5 / CNE Hours: 8:40 a.m. Bicuspid Aortic Valve: TAVR Is Not Ready For Prime Time, SAVR Is Better Co‐Chair: Smadar Kort Joseph E. Bavaria Co‐Chair: Deborah Williams Philadelphia, PA 8:00 a.m. 8:50 a.m. Overview of Appropriate Use Criteria in Cardiac Imaging: Where Have We Panel Discussion With Audience Question and Answer Been? Where Are We Now? John U. Doherty 9:00 a.m. Philadelphia, PA Aortic Insufficiency: TAVR Is a Good Option Satya Shreenivas 8:15 a.m. Cincinnati, OH Imaging For a Lifetime: Should My Patient’s Age or Risk Level Determine My Choice of Imaging Modality? 9:10 a.m. Linda D. Gillam Aortic Insufficiency: Don’t Think About TAVR, SAVR For All! Morristown, NJ Basel Ramlawi Winchester, VA 8:30 a.m. Case Presentation: 85 Year Old With Chest Pain And Multiple Comorbidities 9:20 a.m. Gwen Bernacki Panel Discussion With Audience Question and Answer Bellevue, WA Interventional Cardiology ‐ Scientific 8:35 a.m. Session #605 When Survival Is Not The Only Goal: What Is The Role of Cardiac Imaging in Coronary Physiology: New Tools and Emerging Concepts Palliative Care? Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. James N. Kirkpatrick Room S103d Lake Forest Park, WA CME Hours: 1.5 / CNE Hours: 8:50 a.m. Co‐Chair: William Fuller Fearon Patient vs. Society in Cardiac Imaging: What to Do When The “Good of The Co‐Chair: Eric Alan Osborn Many” Conflicts With The “Good of The Few, or The One”? Panelist: Hector Manuel Garcia Garcia Jennifer H. Mieres Panelist: Abbey E. Gilbert Lake Success, NY Panelist: Abdul Rahman Ihdayhid Panelist: Paul Knaapen 9:05 a.m. Question and Answer 8:00 a.m. CT‐FFR, Angio‐FFR, OCT‐FFR: End of The Pressure Wire? Interventional Cardiology ‐ Scientific William Fuller Fearon Session #604 Stanford, CA Aortic Valve Interventions: Expanding Indications Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. 8:10 a.m. Room S102c Panel Discussion With Audience Question and Answer CME Hours: 1.5 / CNE Hours: 8:16 a.m. Co‐Chair: Saif Anwaruddin Impact of CT‐FFR on Clinical Outcomes Co‐Chair: Katherine Harrington Manesh R. Patel Panelist: Victor Mauri Durham, NC Panelist: Michael Querijero Panelist: Yasser Ahmed Sadek 8:24 a.m. Panelist: Molly Szerlip Procedural Planning Using CT‐FFR Virtual Stenting (BOWIE Trial) Program PDF Saturday, March 28, 2020 Updated: 02-14-20 Eric Van Belle Panel Discussion With Audience Question and Answer Lille Cedex, France 8:30 a.m. 8:32 a.m. Role of Platelet Function And Genetic Testing in 2019 A Growing Menu of Options: How to Intelligently Diagnose Coronary Disease Daniel Aradi in Today's Testing Environment? Balatonfured, Hungary Yuk Kong Lau Central, Hong Kong 8:38 a.m. Panel Discussion With Audience Question and Answer 8:40 a.m. Panel Discussion With Audience Question and Answer 8:45 a.m. Is It Time to Drop Aspirin? 8:46 a.m. Usman Baber Angiography‐Based FFR: Principles And Accuracy Compared to FFR (FAST‐FFR New York, NY Study) Allen Jeremias 8:53 a.m. Roslyn, NY Panel Discussion With Audience Question and Answer 8:54 a.m. 9:00 a.m. Case Presentation: Step‐by‐Step PCI Planning With Angio‐FFR / QFR Oral Antiplatelet Therapy in STEMI: Crushing , Chewing And Timing of Paul David Morris Administration Sheffield, VA, United Kingdom Gilles Montalescot Paris, France 9:02 a.m. Panel Discussion With Audience Question and Answer 9:08 a.m. Panel Discussion With Audience Question and Answer 9:08 a.m. OCT‐FFR: Principles And Accuracy Compared to FFR 9:15 a.m. Shengxian Tu Timing of Administration of Oral Antiplatelet Therapy in NSTEMI: Practical Shanghai, China Considerations Philippe Gabriel Steg 9:16 a.m. Paris, France Case Presentation: Step‐by‐Step PCI Optimization With OCT‐FFR Fumiyasu Seike 9:23 a.m. New York, NY Panel Discussion With Audience Question and Answer 9:24 a.m. Prevention ‐ Scientific Panel Discussion With Audience Question and Answer Session #607 Cardioendocrinology: Who Owns This Emerging Field? Interventional Cardiology ‐ Scientific Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. Session #606 Room S402b Unanswered Questions in Antiplatelet Therapy CME Hours: 1.5 / CNE Hours: Saturday, March 28, 2020, 8:00 a.m. ‐ 9:30 a.m. Room S104b Co‐Chair: Dave L. Dixon CME Hours: 1.5 / CNE Hours: Co‐Chair: Darren K. McGuire Panelist: Prakash C. Deedwania Co‐Chair: Dominick J. Angiolillo Panelist: Dave L. Dixon Co‐Chair: Philippe Gabriel Steg Panelist: Gregg C. Fonarow Panelist: Craig J. Beavers Panelist: Mikhail Kosiborod Panelist: Mina Madan Panelist: Laurence S. Sperling Panelist: Naveen L. Pereira Panelist: Mohamed Seleem 8:00 a.m. SGLT‐2 Inhibitors & GLP‐1 Agonists: Review of Outcome Studies 8:00 a.m. Prakash C. Deedwania Management of Antiplatelet Therapy in Patients Undergoing Non‐cardiac Fresno, CA Surgery Roberta Rossini 8:12 a.m. Cuneo, Italy Pharmacology For The Clinician: SGLT‐2 Inhibitors & GLP‐1 Agonists Dave L. Dixon 8:08 a.m. Richmond, VA Panel Discussion With Audience Question and Answer 8:24 a.m. 8:15 a.m. Patient With CVD And Diabetes: What to Choose And How to Start Switching Antiplatelet Therapy: How, When, Which Dose? Laurence S. Sperling Mrinal Kanti Das Atlanta, GA Koikata, India 8:36 a.m. 8:23 a.m. Heart Failure Benefits: Integrating With GDMT Program PDF Saturday, March 28, 2020 Updated: 02-14-20 Gregg C. Fonarow 12:00 p.m. Los Angeles, CA Heart Songs Moderator Christina Dunbar Matos 8:48 a.m. Roanoke, VA Managing Diabetes in a Cardiology Practice: If Yes, How? Mikhail Kosiborod 3:00 p.m. Leawood, KS Heart Songs Moderator Courtney Bennett 9:00 a.m. Rochester, MN Panel Discussion 3:00 p.m. Special ‐ Special Heart Songs Moderator Session #401 Kathy S.